These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31181882)

  • 1. A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia.
    Marín-Ramos NI; Balabasquer M; Ortega-Nogales FJ; Torrecillas IR; Gil-Ordóñez A; Marcos-Ramiro B; Aguilar-Garrido P; Cushman I; Romero A; Medrano FJ; Gajate C; Mollinedo F; Philips MR; Campillo M; Gallardo M; Martín-Fontecha M; López-Rodríguez ML; Ortega-Gutiérrez S
    J Med Chem; 2019 Jul; 62(13):6035-6046. PubMed ID: 31181882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway.
    Pan Q; Liu R; Banu H; Ma L; Li H
    Biomed Pharmacother; 2018 Mar; 99():169-175. PubMed ID: 29331763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo.
    Lau HY; Ramanujulu PM; Guo D; Yang T; Wirawan M; Casey PJ; Go ML; Wang M
    Cancer Biol Ther; 2014 Sep; 15(9):1280-91. PubMed ID: 24971579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation.
    Liu Q; Chen J; Fu B; Dai J; Zhao Y; Lai L
    Biochem Biophys Res Commun; 2018 Jun; 501(2):556-562. PubMed ID: 29746868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer.
    Manu KA; Chai TF; Teh JT; Zhu WL; Casey PJ; Wang M
    Mol Cancer Ther; 2017 May; 16(5):914-923. PubMed ID: 28167504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth.
    Wang M; Hossain MS; Tan W; Coolman B; Zhou J; Liu S; Casey PJ
    Oncogene; 2010 Sep; 29(35):4959-70. PubMed ID: 20622895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.
    Zhu Y; Hu Q; Li H
    Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms.
    Lau HY; Tang J; Casey PJ; Wang M
    Oncogene; 2017 Jul; 36(27):3934-3942. PubMed ID: 28192404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells.
    Wang M; Tan W; Zhou J; Leow J; Go M; Lee HS; Casey PJ
    J Biol Chem; 2008 Jul; 283(27):18678-84. PubMed ID: 18434300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The isoprenoid substrate specificity of isoprenylcysteine carboxylmethyltransferase: development of novel inhibitors.
    Anderson JL; Henriksen BS; Gibbs RA; Hrycyna CA
    J Biol Chem; 2005 Aug; 280(33):29454-61. PubMed ID: 15946942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents.
    Yang WS; Yeo SG; Yang S; Kim KH; Yoo BC; Cho JY
    Amino Acids; 2017 Sep; 49(9):1469-1485. PubMed ID: 28631011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.
    Winter-Vann AM; Baron RA; Wong W; dela Cruz J; York JD; Gooden DM; Bergo MO; Young SG; Toone EJ; Casey PJ
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4336-41. PubMed ID: 15784746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT).
    Judd WR; Slattum PM; Hoang KC; Bhoite L; Valppu L; Alberts G; Brown B; Roth B; Ostanin K; Huang L; Wettstein D; Richards B; Willardsen JA
    J Med Chem; 2011 Jul; 54(14):5031-47. PubMed ID: 21661760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt).
    Ramanujulu PM; Yang T; Yap SQ; Wong FC; Casey PJ; Wang M; Go ML
    Eur J Med Chem; 2013 May; 63():378-86. PubMed ID: 23514631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino derivatives of indole as potent inhibitors of isoprenylcysteine carboxyl methyltransferase.
    Go ML; Leow JL; Gorla SK; Schüller AP; Wang M; Casey PJ
    J Med Chem; 2010 Oct; 53(19):6838-50. PubMed ID: 20809634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and pharmacologic analyses of the role of Icmt in Ras membrane association and function.
    Svensson AW; Casey PJ; Young SG; Bergo MO
    Methods Enzymol; 2006; 407():144-59. PubMed ID: 16757321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism.
    Teh JT; Zhu WL; Ilkayeva OR; Li Y; Gooding J; Casey PJ; Summers SA; Newgard CB; Wang M
    Oncogene; 2015 Jun; 34(25):3296-304. PubMed ID: 25151967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukemia.
    Sun WT; Xiang W; Ng BL; Asari K; Bunte RM; Casey PJ; Wang M; Chuah C
    Exp Hematol; 2016 Mar; 44(3):189-93.e2. PubMed ID: 26706195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoprenylcysteine carboxyl methyltransferase is critical for glioblastoma growth and survival by activating Ras/Raf/Mek/Erk.
    Wan W; Xiao W; Pan W; Chen L; Liu Z; Xu J
    Cancer Chemother Pharmacol; 2022 Mar; 89(3):401-411. PubMed ID: 35171349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells.
    Zhao Y; Fan D; Ru B; Cheng KW; Hu S; Zhang J; Li ET; Wang M
    Eur J Cancer; 2016 Nov; 68():38-50. PubMed ID: 27710830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.